Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1985-09-10
1986-07-08
Evans, J. E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
2605005H, C07C 8310, A61K 31085, A61K 31165, A61K 31185
Patent
active
045993610
ABSTRACT:
This disclosure relates to a novel class of hydroxamic acid based collagenase inhibitor derivatives. The disclosure further relates to pharmaceutical compositions containing such compounds and to the use of such compounds and compositions in the treatment of collagenase induced diseases.
REFERENCES:
patent: 3247197 (1966-04-01), Gaeumann et al.
patent: 3471476 (1969-10-01), Gaeumann et al.
patent: 4028401 (1977-06-01), Fessler et al.
patent: 4077998 (1978-03-01), Fessler et al.
patent: 4105789 (1978-08-01), Ondetti et al.
patent: 4397867 (1983-08-01), Blake
patent: 4419365 (1983-12-01), McLachlan
Dickens Jonathan P.
Donald David K.
Kneen Geoffrey
McKay William R.
Evans J. E.
G. D. Searle & Co.
Odre Steven M.
LandOfFree
Hydroxamic acid based collagenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid based collagenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid based collagenase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1451434